Overexpression of epidermal growth factor receptors including human epidermal growth factor receptor (EGFR/HER) has been demonstrated in bladder cancer and may offer both prognostic indicators as well as a potential targeted treatment for metastatic bladder cancer with recommendations suggesting to be used as a supplement to conventional chemotherapy. The gene discussed is EGFR; the disease is urinary bladder cancer.